Ledger.Open graph →

SEC Form D · filed February 1, 2013

Morria Biopharmaceuticals PLC

Offering

$10.0M

Sold

$931K

Exemption

—

Industry

Biotechnology

Location

LONDON, United Kingdom

Type

—

People & firms on this filing (15)

Mark Cohen · New York, NYDirector Amos Eiran · Herzeliya, L3Director Saul Yedgar · Jerusalem, L3Exec · Director Terry L. Meadors · Cincinnati, OHDirector Yuval Cohen · Bethesda, MDExec · Director Dov Elefant · New York, NYExec Maziyar Yousefizad · Gainesville, FLDirector Thomas Alessi · Hayward, CAExec · Director Coke Reed · Austin, TXDirector Allan Haims · North Hollywood, CADirector Yuval Cohen · New York, NYExec · Director Dov Elefant · London, United KingdomExec Gilead Raday · Kefar-Uria, L3Director Alan Harris · New York, NYExec David Sidransky · Somerset, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗